Sarki A. Abdulkadir, MD, PhD, discusses the challenges of targeting MYC in prostate cancer.
Sarki A. Abdulkadir, MD, PhD
Advertisement
Articles by Sarki A. Abdulkadir, MD, PhD
Sarki A. Abdulkadir, MD, PhD, discusses the rationale to target MYC in prostate cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
2025 Data Across Gynecologic, Lung, and Hematologic Cancers Reshape Treatment Landscapes
4
Third NDA for Rivoceranib/Camrelizumab Is Resubmitted to FDA for Unresectable HCC
5